Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Haemoglobinopathies Market: By Type: Thalassemia, Sickle Cell Disease; By Test Type: Routine Red Blood Cell (RBC) Count, Genetic Testing; By End Use; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Value Chain Analysis; Manufacturing Process; Competitive Landscape; Industry Events and Developments

Global Haemoglobinopathies Market Outlook

The global haemoglobinopathies market is expected to grow at a CAGR of 7.8% in the forecast period of 2021-2026.

 

Global Haemoglobinopathies Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The Asia Pacific is Expected to Provide Enhanced Growth Opportunities for the Haemoglobinopathies Industry

North America significantly contributes to the growth of the industry owing to the presence of advanced healthcare facilities, better reimbursement policies, and growing R&D activities in the region. The growing prevalence of haemoglobinopathies in European countries, particularly Germany, is also contributing to the industry growth. Meanwhile, the Asia Pacific is expected to witness a healthy growth over the forecast period owing to the unmet needs of the patients suffering from haemoglobinopathies. The growing awareness regarding haemoglobinopathies, improving healthcare infrastructures, and favourable government initiatives are propelling the market growth in the Asia Pacific.

 

Haemoglobinopathies: Industry Definition and Segmentation

Haemoglobinopathies refer to a group of genetic disorders that affect red blood cells or the structure or production of the haemoglobin molecule. Encompassing all genetic diseases of haemoglobin, hemoglobinopathies are the most common monogenic diseases. They fall into two main groups, namely, thalassemia syndromes and structural haemoglobin variants (abnormal haemoglobins). The clinical manifestations of these disorders are highly variable and can range from mild hypochromic anaemia to moderate haematological disease to severe, lifelong, transfusion-dependent anaemia having multiorgan involvement.

 

Global Haemoglobinopathies Market By Type

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on type, the market is divided into:

  • Thalassemia
  • Sickle Cell Disease
  • Others

Among these, the thalassemia segment is further bifurcated into alpha thalassemia and beta thalassemia on the basis of type

On the basis of test type, the industry can be segmented into:

  • Routine Red Blood Cell (RBC) Count
  • Genetic Testing
  • Haemoglobin by High Performance Liquid Chromatography
  • Haemoglobin Isoelectric Focusing (Hb IEF)
  • Haemoglobin Electrophoresis (Hb ELP)
  • Haemoglobin Solubility Test
  • Others

Based on end use, the industry can be categorised into:

  • Hospitals
  • Diagnostics Laboratories
  • Clinics
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Haemoglobinopathies Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Growing Prevalence of Haemoglobinopathies and Increasing Diagnostic Facilities to Bolster the Haemoglobinopathies Industry Growth

The rising incidences of haemoglobinopathies across the globe and the increasing health awareness are driving the growth of the global market for haemoglobinopathies. The market is being supported by the favourable government initiatives to create awareness regarding haemoglobinopathies and the presence of improved diagnostic facilities, particularly in developing nations. Other factors like the growing adoption of Big Data and AI in the healthcare sector, growing focus on patient care, and growing healthcare infrastructures are further propelling the market growth. Over the forecast period, the growing R&D activities are expected to have a positive effect on the expansion of the global haemoglobinopathies industry.

 

Key Industry Players in the Global Haemoglobinopathies Market

The report gives a detailed analysis of the following key players in the global haemoglobinopathies market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Sanofi
  • Bluebird Bio, Inc.
  • Emmaus Medical, Inc.
  • Prolong Pharmaceuticals, LLC.
  • Global Blood Therapeutics, Inc.
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Haemoglobinopathies Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Haemoglobinopathies Historical Market (2016-2020) 
    8.3    Global Haemoglobinopathies Market Forecast (2021-2026)
    8.4    Global Haemoglobinopathies Market by Type
        8.4.1    Thalassemia
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
            8.4.1.4    Breakup by Type
                8.4.1.4.1    Alpha Thalassemia
                    8.4.1.4.1.1    Market Share
                    8.4.1.4.1.2    Historical Trend (2016-2020)
                    8.4.1.4.1.3    Forecast Trend (2021-2026)
                8.4.1.4.2    Beta Thalassemia
                    8.4.1.4.2.1    Market Share
                    8.4.1.4.2.2    Historical Trend (2016-2020)
                    8.4.1.4.2.3    Forecast Trend (2021-2026)
        8.4.2    Sickle Cell Disease
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
        8.4.3    Others
    8.5    Global Haemoglobinopathies Market by Test Type
        8.5.1    Routine Red Blood Cell (RBC) Count
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2016-2020)
            8.5.1.3    Forecast Trend (2021-2026)
        8.5.2    Genetic Testing
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2016-2020)
            8.5.2.3    Forecast Trend (2021-2026)
        8.5.3    Haemoglobin by High Performance Liquid Chromatography
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2016-2020)
            8.5.3.3    Forecast Trend (2021-2026)
        8.5.4    Haemoglobin Isoelectric Focusing (Hb IEF)
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2016-2020)
            8.5.4.3    Forecast Trend (2021-2026)
        8.5.5    Haemoglobin Electrophoresis (Hb ELP)
            8.5.5.1    Market Share
            8.5.5.2    Historical Trend (2016-2020)
            8.5.5.3    Forecast Trend (2021-2026)
        8.5.6    Haemoglobin Solubility Test
            8.5.6.1    Market Share
            8.5.6.2    Historical Trend (2016-2020)
            8.5.6.3    Forecast Trend (2021-2026)
        8.5.7    Others
    8.6    Global Haemoglobinopathies Market by End Use
        8.6.1    Hospitals
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2016-2020)
            8.6.1.3    Forecast Trend (2021-2026)
        8.6.2    Diagnostics Laboratories
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2016-2020)
            8.6.2.3    Forecast Trend (2021-2026)
        8.6.3    Clinics
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2016-2020)
            8.6.3.3    Forecast Trend (2021-2026)
        8.6.4    Others
    8.7    Global Haemoglobinopathies Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2016-2020)
        9.1.2    Forecast Trend (2021-2026)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2016-2020)
        9.2.2    Forecast Trend (2021-2026)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2016-2020)
        9.3.2    Forecast Trend (2021-2026)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2016-2020)
        9.4.2    Forecast Trend (2021-2026)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2016-2020)
        9.5.2    Forecast Trend (2021-2026)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Sanofi
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Bluebird Bio, Inc.
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Emmaus Medical, Inc.
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Prolong Pharmaceuticals, LLC.
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Global Blood Therapeutics, Inc.
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Others
13    Industry Events and Developments

 

List of Figures and Tables

1.    Global Haemoglobinopathies Market: Key Industry Highlights, 2016 and 2026
2.    Global Haemoglobinopathies Historical Market: Breakup by Form (USD Million), 2016-2020
3.    Global Haemoglobinopathies Market Forecast: Breakup by Form (USD Million), 2021-2026
4.    Global Haemoglobinopathies Historical Market: Breakup by Application (USD Million), 2016-2020
5.    Global Haemoglobinopathies Market Forecast: Breakup by Application (USD Million), 2021-2026
6.    Global Haemoglobinopathies Historical Market: Breakup by Region (USD Million), 2016-2020
7.    Global Haemoglobinopathies Market Forecast: Breakup by Region (USD Million), 2021-2026
8.    North America Haemoglobinopathies Historical Market: Breakup by Country (USD Million), 2016-2020
9.    North America Haemoglobinopathies Market Forecast: Breakup by Country (USD Million), 2021-2026
10.    Europe Haemoglobinopathies Historical Market: Breakup by Country (USD Million), 2016-2020
11.    Europe Haemoglobinopathies Market Forecast: Breakup by Country (USD Million), 2021-2026
12.    Asia Pacific Haemoglobinopathies Historical Market: Breakup by Country (USD Million), 2016-2020
13.    Asia Pacific Haemoglobinopathies Market Forecast: Breakup by Country (USD Million), 2021-2026
14.    Latin America Haemoglobinopathies Historical Market: Breakup by Country (USD Million), 2016-2020
15.    Latin America Haemoglobinopathies Market Forecast: Breakup by Country (USD Million), 2021-2026
16.    Middle East and Africa Haemoglobinopathies Historical Market: Breakup by Country (USD Million), 2016-2020
17.    Middle East and Africa Haemoglobinopathies Market Forecast: Breakup by Country (USD Million), 2021-2026
18.    Global Haemoglobinopathies Market Structure

Key Questions Answered in the Report

The global haemoglobinopathies market is projected to grow at a CAGR of 7.8% between 2021 and 2026.

The major drivers of the industry, such as the increasing health awareness, growing prevalence of haemoglobinopathies, favourable government initiatives, and advancements in medical sector, are expected to aid the market growth.

The key market trends guiding the growth of the industry include the growing R&D activities and the rapid technological advancements in the healthcare sector.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The leading types of haemoglobinopathies in the market are thalassemia and sickle cell disease, among others.

The major test types in the industry are routine red blood cell (RBC) count, genetic testing, haemoglobin by high performance liquid chromatography, haemoglobin isoelectric focusing (Hb IEF), haemoglobin electrophoresis (Hb ELP), and haemoglobin solubility test, among others.

The significant end use sectors in the market are hospitals, diagnostics laboratories, and clinics, among others.

The major players in the industry are Sanofi, Bluebird Bio, Inc., Emmaus Medical, Inc., Prolong Pharmaceuticals, LLC., and Global Blood Therapeutics, Inc., among others.

Analyst Review

The global haemoglobinopathies market is being driven by the rising prevalence of haemoglobinopathies. Aided by the technological advancements, the market is expected to witness a healthy growth in the forecast period of 2021-2026, growing at a CAGR of 7.8%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. By type, the market is segmented into thalassemia and sickle cell disease, among others. Based on test type, the industry is divided into routine red blood cell (RBC) count, genetic testing, haemoglobin by high performance liquid chromatography, haemoglobin isoelectric focusing (Hb IEF), haemoglobin electrophoresis (Hb ELP), and haemoglobin solubility test, among others. On the basis of end use, the market is divided into hospitals, diagnostics laboratories, and clinics, among others. The major regional markets for haemoglobinopathies are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Sanofi, Bluebird Bio, Inc., Emmaus Medical, Inc., Prolong Pharmaceuticals, LLC., and Global Blood Therapeutics, Inc., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 1999     $1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

Global Yoga Market Report and Forecast 2021-2026


Global Cytokine Market Report and Forecast 2021-2026


Global Unna Boot Market Report and Forecast 2021-2026


Global Radiodermatitis Market Report and Forecast 2021-2026


Global Medical Nonwoven Disposables Market Report and Forecast 2021-2026


NEWSLETTER